Appointment of Joint Corporate Broker

By

Regulatory News | 05 Nov, 2024

Updated : 09:21

RNS Number : 9867K
IMI PLC
05 November 2024
 

5 November 2024

 

IMI plc

Appointment of Joint Corporate Broker

 

IMI plc, the specialist engineering group, today announces the appointment of Deutsche Numis, as its joint broker, alongside existing broker J.P. Morgan Cazenove, with immediate effect.

Enquiries to:

IMI

Edward Hann                                                                      Tel:  +44 (0)7977 354 810

 

Deutsche Numis

Jonathan Wilcox, George Price                                            Tel:  +44 (0)2072 601 000

 

J.P. Morgan Cazenove

Robbie Constant, Charles Oakes                                         Tel:  +44 (0)2077 424 000

 

Headland PR

Matt Denham                                                                      Tel:  +44 (0)7551 825 496

 

Notes to Editors

IMI plc, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids.  Its innovative technologies, built around valves and actuators, enable vital processes to operate safely, sustainably, cleanly, efficiently and cost effectively.  IMI employs around 10,000 people, has manufacturing facilities in 18 countries and operates a global service network.  The Company is listed on the London Stock Exchange.  Further information is available at www.imiplc.com.

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF751R30.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPFIFLALDLEIIS

Last news